Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | -0.53% | +14.02% | -6.03% |
May. 14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
May. 13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 55.24M | Sales 2025 * | 64.37M | Capitalization | 32.46M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -18M | EV / Sales 2024 * | 0.59 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.5 x |
P/E ratio 2024 * |
-1.58
x | P/E ratio 2025 * |
-1.92
x | Employees | 177 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.53% |
Latest transcript on Exagen Inc.
1 day | -0.53% | ||
1 week | +14.02% | ||
Current month | +34.98% | ||
1 month | +36.50% | ||
3 months | -11.37% | ||
6 months | +19.87% | ||
Current year | -6.03% |
Managers | Title | Age | Since |
---|---|---|---|
John Aballi
CEO | Chief Executive Officer | 39 | 22-10-16 |
Kamal Adawi
DFI | Director of Finance/CFO | 45 | 17-05-31 |
Ming-Chou Lee
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Robertson
BRD | Director/Board Member | 61 | 19-07-29 |
Paul Kim
BRD | Director/Board Member | 56 | 23-07-23 |
Wendy Johnson
BRD | Director/Board Member | 72 | 20-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 1.87 | -0.53% | 33,318 |
24-05-17 | 1.88 | -0.53% | 31,324 |
24-05-16 | 1.89 | -1.05% | 76,879 |
24-05-15 | 1.91 | +8.52% | 144,905 |
24-05-14 | 1.76 | +7.32% | 351,463 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.03% | 32.46M | |
+20.09% | 85.14B | |
-27.30% | 72.06B | |
+2.89% | 27.07B | |
-9.00% | 17.43B | |
-2.10% | 16.98B | |
+4.56% | 16.02B | |
+69.72% | 13.06B | |
+4.06% | 12.9B | |
+73.30% | 12.79B |
- Stock Market
- Equities
- XGN Stock